Proxyphylline

羟丙茶碱

Report date: 2022/08/09 18:06:09
NME

Base Information

Drug NameProxyphylline
Drug Alias Name丙羟茶碱proxifilinaproxyphylline羟丙茶碱proxyphyllinum +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesteraseAdenosine A1 receptorAdenosine A2a receptor
Therapy Area/IndicationsBronchiectasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesHangzhou Minsheng Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHangzhou Minsheng Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsBronchiectasis

Other Information

ATC CodeR03DA03
Related LinksWikipediaKEGG